Assert-IQ vs Rhythm360

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Assert-IQ

by Abbott

Rhythm360

by RhythmScience

AI Verdict

Assert-IQ is an insertable cardiac monitor system focused on long-term, continuous arrhythmia detection through its proprietary device. In contrast, Rhythm360 is an AI-powered platform designed to aggregate and analyze cardiac monitoring data from various vendor devices, streamlining workflow and providing actionable insights. While both leverage AI in cardiology, Assert-IQ generates monitoring data, whereas Rhythm360 optimizes the management and interpretation of such data from multiple sources.

Choose Assert-IQ if…

Choose Assert-IQ if your primary need is long-term, continuous, and highly accurate cardiac monitoring for patients with suspected or intermittent arrhythmias that may not be captured by external devices. This system is ideal for diagnosing elusive heart rhythm disorders over several years, providing detailed data directly from an insertable device for comprehensive management.

View Assert-IQ →

Choose Rhythm360 if…

Choose Rhythm360 if your organization requires a comprehensive, vendor-neutral platform to aggregate and analyze cardiac monitoring data from a diverse range of devices across a large patient base. This solution is best suited for improving operational efficiency, reducing alert fatigue through AI-driven triage, and streamlining billing processes within a busy cardiology practice or health system.

View Rhythm360 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Assert-IQ	Rhythm360
Pricing	Unknown	Flexible pricing model that scales with clinic size and platform usage.
Deployment	Subcutaneously implanted device with mobile app connectivity	Cloud-based SaaS platform
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Unknown
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rhythm360

Rhythm360 (Tool B) offers superior usability through its HIPAA-compliant mobile application for clinicians, bi-directional EHR integration, and AI-driven alert triage. Assert-IQ (Tool A), while providing a patient activator, lacks a dedicated clinician mobile app and API, which are crucial for modern clinical workflow integration and ease of use.

Clinical Value

Rhythm360

While Assert-IQ (Tool A) provides essential long-term cardiac monitoring and advanced arrhythmia detection, Rhythm360 (Tool B) offers broader clinical value by unifying data from various devices, providing actionable insights for hypertension and heart failure management, and significantly reducing alert fatigue. Its predictive algorithms and optional 24/7/365 oversight by CCTs further enhance its utility across a wider range of cardiac care needs.

Pricing & Value

Rhythm360

Rhythm360 (Tool B) offers a more transparent and flexible SaaS-based pricing model that scales with clinic size and platform usage, allowing for better cost management and predictability. Assert-IQ (Tool A) uses an enterprise pricing model requiring direct contact for institutional pricing, which offers less initial transparency.

Enterprise Readiness

Rhythm360

Rhythm360 (Tool B) demonstrates stronger enterprise readiness with its extensive bi-directional EHR integrations (Epic, Cerner, etc.), cloud-based SaaS deployment, and AI Data Normalization capabilities via API. Assert-IQ (Tool A), while FDA cleared and from a large company, does not explicitly mention EHR integration or API availability, which are critical for seamless enterprise-level adoption and interoperability. Rhythm360 also received FDA 510(k) clearance in 2022 for its AI-powered cardiac monitoring platform.

Innovation

Rhythm360

Rhythm360 (Tool B) showcases greater innovation through its vendor-neutral data aggregation from all major OEMs, AI-driven alert triage for 80% faster response times, automated CPT code documentation and billing, and predictive algorithms for heart failure management. Assert-IQ (Tool A)'s innovation is primarily within its specific device technology for long-term monitoring, whereas Rhythm360's platform approach addresses broader workflow and data integration challenges in cardiac care.

Support & Docs

Assert-IQ

Abbott Medical (Tool A), as a large and established medical device company, is known for providing comprehensive support, documentation, and training resources for its products. While Rhythm360 (Tool B) offers valuable optional 24/7/365 oversight by certified cardiac technicians, the general breadth and depth of product support and documentation are likely more robust and established from a company of Abbott's scale.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Assert-IQ	Rhythm360
Name	Assert-IQ	Rhythm360
Company	Abbott Medical	RhythmScience
Mobile Application	none	HIPAA-compliant mobile application for clinicians
Primary Function	Long-term, continuous monitoring and advanced arrhythmia detection via an Insertable Cardiac Monitor (ICM) system.	AI-powered integrated platform unifying cardiac monitoring data from various devices for actionable insights and reduced alert fatigue.
AI/Alert Management	Advanced arrhythmia detection algorithms, proactive clinician alerts.	AI-driven alert triage (80% faster response times, reduces alert fatigue).
EHR Integration	Not specified	Bi-directional EHR integration (Epic, Cerner, Athenahealth, eClinicalWorks, GreenwayHealth, GE Centricity).

Videos

Demos, reviews, and walkthroughs featuring Assert-IQ and Rhythm360.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the fundamental difference in how these tools provide cardiac monitoring and data management?

Assert-IQ is an Insertable Cardiac Monitor (ICM) system that directly provides long-term, continuous monitoring and advanced arrhythmia detection through its proprietary device. In contrast, Rhythm360 is an AI-powered integrated platform designed to unify and analyze cardiac monitoring data from various devices, including those from major OEMs like Abbott, Medtronic, and Boston Scientific.

How do these tools integrate with existing electronic health record (EHR) systems and other cardiac monitoring devices?

Assert-IQ utilizes a secure cloud-based data platform and the myMerlin mobile app for data transmission, but explicit bi-directional EHR integration is not specified. Rhythm360 offers bi-directional EHR integration with major systems such as Epic, Cerner, Athenahealth, and eClinicalWorks, and provides vendor-neutral data aggregation from all major OEM cardiac devices, using APIs, HL7, XML, and PDF parsing.

Which tool offers features to help manage alert fatigue and automate administrative tasks for clinicians?

Assert-IQ provides proactive clinician alerts and uses AI algorithms to reduce false positives for AF and Pause episodes, aiming to reduce data burden. Rhythm360 features AI-driven alert triage to reduce alert fatigue by prioritizing clinically significant events, and it offers automated CPT code documentation and billing for codes like 93298, 93299, 99454, and 99453.

Do these tools provide mobile access for clinicians to monitor patient data remotely?

Assert-IQ uses the myMerlin mobile app primarily for patients to transmit data from their ICM and log symptoms. Rhythm360 offers a HIPAA-compliant mobile application specifically for clinicians, allowing them to review transmissions, sign reports, and coordinate care from any location.

What is the scope of cardiac conditions each tool addresses beyond basic rhythm monitoring?

Assert-IQ focuses on long-term continuous cardiac monitoring and advanced arrhythmia detection, including conditions like atrial fibrillation, bradycardia, tachycardia, and sinus pauses. Rhythm360 provides actionable insights for hypertension, heart failure, and rhythm management, incorporating predictive algorithms for heart failure management and GDMT optimization.

What kind of support or oversight is available with each system?

Assert-IQ offers remote monitoring capabilities and proactive clinician alerts, with some models supporting remote programming by clinicians. Rhythm360 provides optional 24/7/365 oversight by certified cardiac technicians (CCTs) and technical services teams to assist with alert management, patient compliance, and health coaching.